Reuters -- U.S. health officials have halted enrollment of new patients in a clinical trial of GlaxoSmithKline Plc’s (GSK.L) diabetes pill Avandia while regulators consider if the drug should stay on the market.
Reuters -- U.S. health officials have halted enrollment of new patients in a clinical trial of GlaxoSmithKline Plc’s (GSK.L) diabetes pill Avandia while regulators consider if the drug should stay on the market.
